Preview

Nephrology (Saint-Petersburg)

Advanced search

ACTIVITY OF NUCLEOLAR ORGANIZERS AND CLINICAL COURSE OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER

https://doi.org/10.24884/1561-6274-2004-8-3-79-83

Abstract

THE AIM of the investigation was to study activity of nucleolar organizers and clinical course of transitional cell carcinoma of the bladder and to compare clinical and morphological signs with indices of the distribution of nucleoli and argentophilic granules in tumor cells. PATIENTS AND METHODS. Data of the primary examination and of five years of dispensary observation after radical operative treatment of 61 patients with transitional cell carcinoma of the bladder were studied retrospectively. In addition to standard examination the ablated tissues of the tumors were stained with silver nitrate and under 1000 magnification the indices of the distribution of nucleoli and argentophilic granules were counted and analyzed and compared with clinical data taken before operations and during the postoperative dispensary followup. RESULTS. A correlation was revealed between indices of the distribution of nucleoli and nucleolar organizers and gender (p<0.001), age (p=0.077), blood group (p=0.038), rhesus factor (p=0.091), complains to dysuria (p=0.040), macrohematuria (p=0.063), content of erythrocytes (p=0.009) and leukocytes (p=0.015) in peripheral blood, presence of uremia (p<0.001), bacteriuria (p<0.001), leukocyturia (p=0.005), deep invasion (p=0.034) and degree of differentiation (p=0.0009) of carcinoma, as well as of recurrences (p<0.001) of tumors and survival of patients (p=0.021). The investigation of the parameters of distribution of nucleoli and bladder carcinomas granules allowed to specify risk of recurrences and death of patients from progression of the tumors after operative treatment. CONCLUSION. Investigation of activity of nucleolar organizers give additional information on properties of bladder carcinomas and prognosis of the disease.

About the Author

I. A. Korneev
Санкт-Петербургский государственный медицинский университет им.акад.И.П.Павлова
Russian Federation


References

1. Матвеев БП. Клиническая онкоурология. Вердана, М; 2003

2. АльШукри СХ, Ткачук ВН. Опухоли мочеполовых органов. Питер, СПб; 2000

3. Лопаткин НА, Даренков СП, Чернышев ИВ и др. Диагно стика и лечение рака мочевого пузыря. Урология 2004; 1: 1217

4. Bozlu M, Orhan D, Baltaci S et al. The prognostic value of proliferating cell nuclear antigen, Ki67 and nucleolar organizer region in transitional cell carcinoma of the bladder. Int Urol Nephrol 2002; 33(1): 5966

5. Karakok M, Aydin A, Bakir K et al. AgNOR/P53 expression compared with different grades in bladder carcinoma. Int Urol Nephrol 2002; 33(2): 353355

6. Wolf H. Prognostic factors in bladder carcinoma. Scand J Urol Nephrol 1991; 138: 153160

7. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International histological classification of tumours, 10th ed. World Health Organisation, Geneva, 1973

8. Howell WM, Black DA. Controlled silver staining of nucleolus organiser regions with a protective colloidal developer: a one step method. Experientia 1980; 36: 1014–1015

9. Ooms ECM, Veldhuizen RW. Argyrophilic proteins of the nucleolar organiser region in bladder tumors. Virchows Arch A Pathol Anal Histol 1989; 414: 365–369

10. Мационис АЭ, Коган МИ, Матвеенко АА и др. Новые реальности цитологической диагностики рака мочевого пузыря. В: Актуальные вопросы лечения онкоурологических заболеваний: Материалы 4-й Всероссийской научной конференции с участием стран СНГ. Российский онкологический научный центр им. Н.Н.Блохина РАМН, Медицинский радиологический научный центр РАМН, М., 2001; 28 – 30

11. АльШукри СХ, Ткачук ВН. Опухоли мочевого пузыря в пожилом и старческом возрасте. Издательство СПбГМУ, СПб, 1999

12. Llopis B., Ruiz J.L., Server G., Marty M. et al. ABO blood groups and bladder carcinoma. Eur Urol 1990; 17(4): 28992

13. Raitanen MP, Tammela TL. Relationship between blood groups and tumour grade, number, size, stage, recurrence and survival in patients with transitional cell carcinoma of the bladder. Scand J Urol Nephrol 1993; 27(3): 343347

14. Bryne M, Thrane PS, Lilleng R, Dabelsteen E. Prognostic value of Rhesus blood groups in oral squamous cell carcinomas. Cancer 1991; 15;68(10): 22132216

15. Mayer B, Schraut W, Funke I et al. The Rhesus D negative phenotype is an independent predictor of poor prognosis in curatively (RO) resected gastric cancer patients. Br J Cancer 1997;75(9): 12911294

16. Slater G, Itzkowitz S, Azar S, Aufses AH Jr. Clinicopathologic correlations of ABO and Rhesus blood type in colorectal cancer. Dis Colon Rectum 1993; 36(1): 57


Review

For citations:


Korneev I.A. ACTIVITY OF NUCLEOLAR ORGANIZERS AND CLINICAL COURSE OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER. Nephrology (Saint-Petersburg). 2004;8(3):79-83. (In Russ.) https://doi.org/10.24884/1561-6274-2004-8-3-79-83

Views: 343


ISSN 1561-6274 (Print)
ISSN 2541-9439 (Online)